Filing Flows › Cigna (CI) › Guidance & outlook
Cigna (CI) guidance and outlook
Cigna (CI) raised its guidance on Nov 5, 2026: EPS $30.60 for FY2026; Operating cash flow $3.0B for FY2030; Operating income $30.6M for FY2026. Cigna's 10-Q filed Nov 5, 2026 makes 12 forward-looking statements, 3 of them new and 0 no longer said since the filing before.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| EPS | FY2026 | $30.60 | raised |
| Operating cash flow | FY2030 | $3.0B | new |
| Operating income | FY2026 | $30.6M | raised |
From the earnings release filed Nov 5, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 5, 2026
- new · This initiative is intended to enhance the value of our products and services, support our financial commitments and generate cost savings through 2030.
- new · We expect to reinvest a portion of the savings generated by the initiative to support growth and innovation, while a portion will benefit operating results.
- new · The Company's Strategic Optimization Program, which was announced in 2025, will continue as a discrete restructuring program under the broader Accelerate to One initiative with the continued objective to evolve our business and deliver a more efficient and improved experience for our patients, providers and customers.
- Corporate reflects amounts not allocated to operating segments, including net interest expense (defined as interest on corporate financing less net investment income on investments not supporting segment and other operations), certain litigation matters, expense associated with our frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and…
- The Company currently intends to pay regular quarterly dividends, with future declarations subject to approval by our Board of Directors ("Board") and our Board's determination that the declaration of dividends remains in the best interests of The Cigna Group and its shareholders.
- • changes in the estimate or different estimates that could have been selected could have a material effect on our consolidated results of operations or financial condition.
- We believe that the vast majority of our investments will continue to perform under their contractual terms.
- We manage the portfolio for long-term economics; therefore, we expect to hold a significant portion of these assets for the long term.
- Given the quality and diversity of the underlying real estate, positive debt service coverage, loan-to-value ratio and significant borrower cash invested in the property generally ranging between 30% and 40%, we remain confident that the vast majority of borrowers will continue to perform as expected under their contract terms.
- Although future losses remain possible due to further credit deterioration, we do not expect these losses to have a material unfavorable effect on our results of operations, financial condition or liquidity.
- Given our subordinate position in the capital structure of these underlying entities, we assume a higher level of risk for higher expected returns.
- We expect continued volatility in private equity and real estate fund performance going forward as fair market valuations are adjusted to reflect market and portfolio transactions.
Cigna's latest quarter
Cigna, Q3 2026: revenue $73.7B (+6% year over year), operating margin 3.3%, net earnings $1.4B, operating cash flow $2.6B. The chart follows the revenue to costs, profit and cash.
Questions
Did Cigna raise or lower its guidance?
Cigna (CI) raised its guidance on Nov 5, 2026: EPS $30.60 for FY2026; Operating cash flow $3.0B for FY2030; Operating income $30.6M for FY2026.
What does Cigna expect?
This initiative is intended to enhance the value of our products and services, support our financial commitments and generate cost savings through 2030. We expect to reinvest a portion of the savings generated by the initiative to support growth and innovation, while a portion will benefit operating results. The Company's Strategic Optimization Program, which was announced in 2025, will continue as a discrete restructuring program under the broader Accelerate to One initiative with the continued objective to evolve our business and deliver a more efficient and improved experience for our patie
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.